Skip to main content
Clinical Trials/KCT0004052
KCT0004052
Recruiting
未知

A comparative clinical trial to evaluate the efficacy and safety of 'Hwangryenhaedogtang‘ in treatment of gastritis

Pusan National University Korean Medicine Hospital0 sites20 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the digestive system
Sponsor
Pusan National University Korean Medicine Hospital
Enrollment
20
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Pusan National University Korean Medicine Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\) Only those aged 19 or over but under 65
  • 2\) Body mass index (BMI) of more than 25 kg / m2
  • 3\) Those who have been diagnosed with gastritis by gastroscopy
  • 4\) After fully hearing and understanding the details of this clinical trial, you agree to participate voluntarily and agree in writing to abide by the instructions.
  • 5\) Those who can follow up during the clinical trial

Exclusion Criteria

  • 1\) Those who can not undergo gastroscopy
  • 2\) peptic ulcer (except patients with scarring)
  • 3\) Those who have had past gastric acid secretion surgery or stomach and esophagus surgery
  • 4\) A person with a history of gastrointestinal malignancies
  • 5\) In the second week prior to administration of test drug, H2 receptor antagonist, anticholinergic agent (muscarinic receptor antagonist), gastrin receptor antagonist, prostaglandin agent, proton pump inhibitor, gastric mucosal protective agent, One who took it
  • 6\) Those who need to continue taking medications that may affect this test, such as corticosteroids, non\-steroidal anti\-inflammatory drugs, and aspirin
  • 7\) Those taking thrombolytic agents (such as cerebral thrombosis, myocardial infarction, thrombophlebitis), consuming coagulation disorder patients and antithrombotic agents such as warfarin
  • 8\) People with Zollinger\-Ellison syndrome
  • 9\) Those with a history of drug allergy symptoms (rash, fever, itching, etc.)
  • 10\) Patients with abnormal liver function and renal function with serum AST, ALT and creatinine\> 3 times the normal peak

Outcomes

Primary Outcomes

Not specified

Similar Trials